Avaleht › Depressioon › Arkansas
Depressioon kliinilised uuringud osariigis Arkansas
10 uuringut haiguse Depressioon jaoks otsivad osalejaid osariigis Arkansas.
Linnad osariigis Arkansas
Ametlik uuringutekst (inglise keeles)
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Pillar Clinical Research, Bentonville
- SanRo Clinical Research Group, Bryant
VärbamineFaas 3
Vanused 18–74 · Kõik sood · Uuendatud 8. sept 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Little Rock
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. sept 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bentonville
- Draig Clinical Site, Little Rock
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 26. aug 2026 · NCT07300969NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bryant
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 11. aug 2026 · NCT06911112E-Mindfulness Approaches for Living After Breast Cancer
- Mercy Hospital Fort Smith, Fort Smith
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
- University of Arkansas for Medical Sciences, Little Rock
VärbamineFaas 3
Vanused 18–50 · Kõik sood · Uuendatud 4. aug 2026 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Woodland International Research Group, Little Rock
- Woodland Research Northwest, Rogers
VärbamineFaas 3
Vanused 18–74 · Kõik sood · Uuendatud 3. aug 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. juuli 2026 · NCT06966401A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
- Woodland Research Northwest, Rogers
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 11. mai 2026 · NCT06524830Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons
- University of Arkansas for Medical Sciences, Little Rock
- Northeast Arkansas Community Corrections Center (NEACC), Osceola
- Southwest Arkansas Community Correction Center, Texarkana
- ja veel 1
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 21. jaan 2026 · NCT06923423Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Little Rock
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. okt 2025 · NCT06786624Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.